Building Blocks

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

6-Aminonaphthalene-1-sulfonamide is a monoclonal antibody that binds to the tissue-type plasminogen activator (tPA) receptor and stabilizes the tPA molecule. It has been shown to have a protective effect on tPA from inactivation by serine proteases, which may be useful in life-threatening conditions such as myocardial infarction or stroke. 6-Aminonaphthalene-1-sulfonamide is a potential treatment for thromboembolic disease.

Phenothiazine 5-oxide is a potent inhibitor of oxidative reactions that can be used to oxidize phenoxazine. Phenothiazine 5-oxide has been shown to inhibit the oxidation of phenoxazine by sodium hydroxide solution in an electrochemical study. This vibrational, irreversible oxidation reaction was introduced by the introduction of sodium salts, which are potent inhibitors of oxidative reactions. Phenothiazine 5-oxide has been shown to have potent inhibitory activity against cervical cancer cells and shows promise as a chemotherapeutic agent for this type of cancer.

4-Chloro-2-methyl-6-nitroquinoline is an antimicrobial agent that exhibits a broad spectrum of activity against both gram-positive and gram-negative bacteria. It also has antifungal properties. 4-Chloro-2-methyl-6-nitroquinoline inhibits the growth of bacteria by binding to DNA and RNA in the bacterial cell, thereby inhibiting transcription and replication. It also inhibits the synthesis of proteins in fungi, which may be due to its ability to bind to fungal ribosomes and inhibit protein synthesis.

Versatile small molecule scaffold

5-(1H-Indol-3-yl)pentanoic acid is a potent and selective serotonin reuptake inhibitor (SSRI). It has been shown to have a high affinity for the serotonin transporter (SERT), with a binding constant of about 5 nM. The compound has been shown to be bifunctional, which means it can inhibit both serotonin and dopamine reuptake. 5-(1H-Indol-3-yl)pentanoic acid is also orally active, so it can be used in vivo as well as in vitro. This drug has been found to have pharmacokinetic properties that are similar to those of fluoxetine and citalopram. Pharmacophore modeling studies have revealed that this drug binds to the SERT by creating hydrogen bonds with amino acids such as serine, threonine, tyrosine and tryptophan.

(2S)-4-Methyl-2-(4-methylbenzenesulfonamido)pentanoic acid is an inhibitor of aminopeptidases, which are enzymes that catalyze the hydrolysis of peptides and proteins. This drug binds to the active site of the enzyme and inhibits its activity. The inhibition is reversible and competitive. It has been shown that this drug has a high inhibitory effect on aminopeptidases in vitro, but the concentration required for inhibition is higher than the therapeutic level. The interaction between (2S)-4-Methyl-2-(4-methylbenzenesulfonamido)pentanoic acid and chloromethylketone has not been investigated yet.
(2S)-4-Methyl-2-(4-methylbenzenesulfonamido)pentanoic acid is an inhibitor of pancreatic aminopeptidases A, B, C, D,

Versatile small molecule scaffold

Methyl 3-fluoroadamantane-1-carboxylate is a chiral compound. The synthesis of this molecule involves the electrochemical method in which the fluorine atom is added to the phenacyl group, which is attached to a phenyl group. The fluorine atom can be seen in the skeleton and on both the left and right side of the molecule. This molecule belongs to an enantiomer of methyl adamantane-1-carboxylate, which has been studied for its ability to inhibit memantine binding and to produce a variety of functional groups. Methyl 3-fluoroadamantane-1-carboxylate has not been studied extensively and is not commercially available.

Versatile small molecule scaffold

Versatile small molecule scaffold

5-(Dimethylamino)-1-naphthalenesulfonamide (DNS) is a fluorescence probe that can be used to measure the concentration of nonsteroidal anti-inflammatory drugs. It is a competitive inhibitor of the drug transporter protein, and it binds to the drug transporter protein in the cell membrane, which alters its transport activity. This probe has been shown to have a phase transition temperature of about 200 °C, which makes it suitable for use in biological samples that are heated at this temperature. DNS inhibits bacterial growth by binding to DNA-dependent RNA polymerase, thereby preventing transcription and replication. The high frequency of human activity has been shown using a patch-clamp technique on human erythrocytes. This active form is metabolized through a number of metabolic transformations, including hydrolysis by esterases or glucuronidases, oxidation by cytochrome P450 enzymes, reduction by glutathione reductase, or conjugation with gluc

2-(Methylthio)pyrimidine-4,5,6-triamine is a centrosymmetric molecule with a molecular weight of 184.07 g/mol. It forms hydrogen bonds with water and interacts with other molecules. 2-(Methylthio)pyrimidine-4,5,6-triamine has been shown to form stacking interactions in crystal structures due to the presence of hydrogen bonds. Hydrogen bonds are formed between molecules when the partial positive charge on one molecule is attracted to the partial negative charge on another molecule. The attraction between these molecules can be facilitated by the presence of water molecules and is most prevalent in substances that have a high degree of hydrogen bonding potential, such as sugars and proteins.
2-(Methylthio)pyrimidine-4,5,6-triamine has also been shown to form hydrogen bonds with organic compounds such as methanol and ethanol.